Keyphrases
Tumor Necrosis Factor-α
100%
Interferon-α (IFN-α)
100%
Interleukin-2
100%
Cytokine Genes
100%
Gene Transcript
100%
Pulmonary Autograft
100%
Non-resolving Inflammation
75%
Acute Rejection
50%
Complementary DNA (cDNA)
50%
Lung Transplantation
50%
Polymerase Chain Reaction
50%
Obliterative Bronchiolitis
50%
Clinical Evaluation
25%
Bronchoalveolar Lavage
25%
Macrophages
25%
Pretransplant
25%
Biopsy Specimen
25%
Host Response
25%
Histologic
25%
Lymphocyte Cell
25%
Allograft
25%
Diagnosis-related Groups
25%
Oligonucleotide Probes
25%
Effector Cells
25%
Acute Infection
25%
Cytokine Expression
25%
Pathological Examination
25%
Polymerase Chain Reaction Amplification
25%
Reaction Products
25%
Oligonucleotide Primers
25%
Gel Electrophoresis
25%
Dot Blot
25%
Reaction Methodology
25%
Reverse Transcription
25%
Regulatory Cells
25%
Serial Data
25%
Transbronchial Biopsy
25%
Pathologic Conditions
25%
Cell Pellet
25%
Medicine and Dentistry
Cytokine
100%
Tumor Necrosis Factor
100%
Interferon
100%
Allograft
100%
Interleukin 2
100%
Infection
57%
Polymerase Chain Reaction
42%
Acute Graft Rejection
28%
Lung Transplantation
28%
Complementary DNA
28%
Bronchiolitis Obliterans
28%
Oligonucleotide
28%
Clinical Trial
14%
Immune Response
14%
Macrophage
14%
Effector Cell
14%
Biopsy Technique
14%
Gel Electrophoresis
14%
Phosphorus 32
14%
Regulatory Cell
14%
Reverse Transcription
14%
Transbronchial Biopsy
14%
Lung Lavage
14%
Blotting
14%
Lymphocyte
14%
Immunology and Microbiology
interferon
100%
Cytokine
100%
Tumor Necrosis Factor
100%
Interleukin 2
100%
Allograft
100%
Polymerase Chain Reaction
42%
Acute Graft Rejection
28%
Lung Transplantation
28%
Bronchiolitis
28%
Macrophage
14%
Immune Response
14%
Effector Cell
14%
Oligonucleotide Probe
14%
Regulatory Cell
14%
Reverse Transcription
14%
Lymphocyte
14%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Cytokine
100%
Interferon
100%
Interleukin 2
100%
Infection
57%
Inflammation
42%
Complementary DNA
28%
Acute Graft Rejection
28%
Bronchiolitis Obliterans
28%
Oligonucleotide
28%
Clinical Trial
14%
Phosphorus 32
14%
Gel Electrophoresis
14%